Genedata Biologics

Making Biopharma Discovery Faster & Better

Genedata Biologics™ is a first-in-class workflow system that boosts the efficiency of the biologics discovery process. Uniquely designed from the start for large molecules, the system increases throughput and quality during the biologics discovery process and covers therapeutic antibodies, bispecifics and other next-generation molecules, antibody drug conjugates, and therapeutic proteins. The platform supports the full breadth of the large-molecule research process - from screening, protein engineering and optimization, expression, purification, analytics and QC, to candidate developability and manufacturability assessment.

Genedata Biologics supports the design and engineering of superior therapeutic molecules and identifies the best molecules to move forward. By tightly integrating the process of candidate screening, engineering, testing, and selection, the system enables a simultaneous optimization of biological parameters as well as developability and manufacturability parameters, which reduce the risk of encountering unexpected obstacles during development.

Users report up to 50% gains in efficiency and throughput as well as improved quality of results. This is accomplished by tracking and managing all molecules, samples, and testing data in one shared system. A built-in large-molecule registration engine provides unique identification and naming of all biological entities, including proteins, cell lines, and plasmids. All data is shared, making the handover of samples and molecules between collaborating teams more efficient.

Designed as a scalable enterprise solution, Genedata Biologics simultaneously supports hundreds of users, working in a multi-site, cross-department, and division-of-labor environment. The system works out-of-the-box in its default configuration, can be easily integrated with corporate-specific instruments and IT environments, and is available for both single groups as well as large, global installations.

Benefits

Supports all critical stepsin the biologics R&D process – including library management, selection and screening, engineering and optimization, cloning, expression and purification, and analytics and QC

“One of the reasons we chose Genedata Biologics was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.”

Dr. Sergio Rotstein
Director of Research Business Technology, Pfizer

“... supports our scientists in a complex, multi-site environment by providing all the necessary information and tools to streamline the biologics lead generation and optimization process"